Association of the COVID-19 Pandemic With Patterns of Statewide Cancer Services.


Journal

Journal of the National Cancer Institute
ISSN: 1460-2105
Titre abrégé: J Natl Cancer Inst
Pays: United States
ID NLM: 7503089

Informations de publication

Date de publication:
13 06 2022
Historique:
received: 08 03 2021
revised: 03 06 2021
accepted: 16 06 2021
pubmed: 29 6 2021
medline: 16 6 2022
entrez: 28 6 2021
Statut: ppublish

Résumé

The coronavirus disease 2019 (COVID-19) pandemic led to delayed medical care in the United States. We examined changes in patterns of cancer diagnosis and surgical treatment between January 1 and December 31 in 2020 and 2019 with real-time electronic pathology report data from population-based Surveillance, Epidemiology, and End Results cancer registries from Georgia and Louisiana. During 2020, there were 29 905 fewer pathology reports than in 2019, representing a 10.2% decline. Declines were observed in all age groups, including children and adolescents younger than 18 years. The nadir was early April 2020, with 42.8% fewer reports than in April 2019. Numbers of reports through December 2020 never consistently exceeded those in 2019 after first declines. Patterns were similar by age group and cancer site. Findings suggest substantial delays in diagnosis and treatment services for cancers during the pandemic. Ongoing evaluation can inform public health efforts to minimize any lasting adverse effects of the pandemic on cancer diagnosis, stage, treatment, and survival.

Identifiants

pubmed: 34181001
pii: 6307727
doi: 10.1093/jnci/djab122
pmc: PMC9194624
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

907-909

Informations de copyright

Published by Oxford University Press 2021. This work is written by US Government employees and is in the public domain in the US.

Références

JCO Clin Cancer Inform. 2020 Nov;4:1059-1071
pubmed: 33253013
MMWR Morb Mortal Wkly Rep. 2020 Jun 19;69(24):759-765
pubmed: 32555134
JAMA Netw Open. 2020 Aug 3;3(8):e2017267
pubmed: 32749465
J Am Med Inform Assoc. 2020 Jan 1;27(1):89-98
pubmed: 31710668
JCO Clin Cancer Inform. 2020 Jul;4:657-665
pubmed: 32716647
Int J Epidemiol. 2004 Dec;33(6):1389-97
pubmed: 15319402

Auteurs

K Robin Yabroff (KR)

Surveillance and Health Equity Science, American Cancer Society, Atlanta, GA, USA.

Xiao-Cheng Wu (XC)

Louisiana State University Health Sciences Center, School of Public Health, New Orleans, LA, USA.

Serban Negoita (S)

Surveillance Research Program, National Cancer Institute, Rockville, MD, USA.

Jennifer Stevens (J)

Information Management Services, Inc, Calverton, MD, USA.

Linda Coyle (L)

Information Management Services, Inc, Calverton, MD, USA.

Jingxuan Zhao (J)

Surveillance and Health Equity Science, American Cancer Society, Atlanta, GA, USA.

Brent J Mumphrey (BJ)

Louisiana State University Health Sciences Center, School of Public Health, New Orleans , LA, USA.

Ahmedin Jemal (A)

Surveillance and Health Equity Science, American Cancer Society, Atlanta, GA, USA.

Kevin C Ward (KC)

Rollins School of Public Health, Emory University, Atlanta, GA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH